Sign Up to like & get
recommendations!
1
Published in 2023 at "Journal of Enzyme Inhibition and Medicinal Chemistry"
DOI: 10.1080/14756366.2023.2169282
Abstract: Abstract To explore the potential use of CDK inhibitors in pancreatic ductal adenocarcinoma (PDAC) therapy, a series of novel 2-((4-sulfamoylphenyl)amino)-pyrrolo[2,3-d]pyrimidine derivatives was designed, synthesised, and investigated for inhibition on both CDK kinase activity and cellular…
read more here.
Keywords:
sulfamoylphenyl amino;
cdk inhibitors;
pyrrolo pyrimidine;
pyrimidine derivatives ... See more keywords